|Articles|April 14, 2003
Preliminary trials with Light-Adjustable Lens are promising
San Francisco-April 13-The Light-Adjustable Lens (LAL) has entered humanclinical trials with promising results. Four humans-one blind and threewith sight-have received the lens, noted Robert K. Maloney, MD, chief medicalofficer, Calhoun Vision Inc, Pasadena, CA, who spoke at dinner gatheringin San Francisco.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Polyendocrine metabolic ovarian syndrome: looking past the reproductive system to the eye
2
Port Delivery System Therapies in Retinal Vascular Diseases
3
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
4
Safety Considerations in Retinal Vascular Diseases
5


















